ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 3, 2022 to file lead plaintiff applications in a securities class action lawsuit against ON24, Inc., if they purchased the Company’s shares issued in connection with its February 2021 initial public stock offering (the “IPO”). This action is pending in the United States District Court for the Northern […]
Read More>>Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Exicure, Inc. and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Exicure securities between March 11, 2021 and November 15, 2021, inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: www.bgandg.com/xcur. This […]
Read More>>The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Cloopen Group Holding Limited’s American Depositary Shares (“ADSs”) pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) issued in connection with Cloopen’s IPO; and/or securities between February 9, 2021 and May 10, 2021, inclusive (the “Class Period”) have until February 8, 2022 to seek appointment as lead […]
Read More>>Pomerantz LLP announces that a class action lawsuit has been filed against ON24, Inc. and certain of its officers. The class action, filed in the United States District Court for the Northern District of California, and docketed under 21-cv-08744, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired […]
Read More>>The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Revance Therapeutics, Inc. securities between November 25, 2019 and October 11, 2021, inclusive (the “Class Period”) have until February 8, 2022, to seek appointment as lead plaintiff in Aramic LLC v. Revance Therapeutics, Inc., No. 21-cv-09585 (N.D. Cal.). Commenced on December 10, 2021, the Revance Therapeutics class action lawsuit charges Revance Therapeutics along with […]
Read More>>The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Paysafe Limited f/k/a Foley Trasimene Acquisition Corp. II securities between December 7, 2020 and November 10, 2021, inclusive (the “Class Period”) have until February 8, 2022 to seek appointment as lead plaintiff in Wiley v. Paysafe Limited f/k/a Foley Trasimene Acquisition Corp. II, No. 21-cv-10611 (S.D.N.Y.). Commenced on December 10, 2021, the Paysafe class action lawsuit […]
Read More>>The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Organogenesis Holdings Inc. securities between March 17, 2021 and October 11, 2021, inclusive (the “Class Period”) have until February 8, 2022 to seek appointment as lead plaintiff in Somogyi v. Organogenesis Holdings Inc., No. 21-cv-06845 (E.D.N.Y.). Commenced on December 10, 2021, the Organogenesis class action lawsuit charges Organogenesis along with certain of its top executives […]
Read More>>The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Cloopen Group Holding Limited. The action charges Cloopen with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Cloopen’s materially misleading statements […]
Read More>>The law firm of Kessler Topaz Meltzer & Check, LLP informs investors that a securities class action lawsuit has been filed against Paysafe Limited f/k/a Foley Trasimene Acquisition Corp. II. The action charges Paysafe with violations of the federal securities laws, including omissions and fraudulent misrepresentations relating to the company’s business, operations, and prospects. As a result of Paysafe’s […]
Read More>>Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018-2020 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating: Dune Acquisition Corp. (DUNE), a special purpose acquisition company, relating to the proposed merger with Trade Zero Holding Corp. Under the […]
Read More>>